The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Preliminary results of a phase II randomized study (ROMULUS) of polatuzumab vedotin (PoV) or pinatuzumab vedotin (PiV) plus rituximab (RTX) in patients (Pts) with relapsed/refractory (R/R) non-Hodgkin lymphoma (NHL).
Franck Morschhauser
Research Funding - Genentech
Ian Flinn
Research Funding - Genentech
Ranjana H. Advani
Research Funding - Genentech
Laurie Helen Sehn
No relevant relationships to disclose
Kathryn S. Kolibaba
No relevant relationships to disclose
Oliver W. Press
Research Funding - Genentech
Gilles A. Salles
Consultant or Advisory Role - Genentech
Research Funding - Genentech
Catherine S. Magid Diefenbach
Honoraria - Roche
Herve Tilly
Honoraria - Roche
Sarit E. Assouline
No relevant relationships to disclose
Andrew Tzong-Yow Chen
Consultant or Advisory Role - Genentech
Martin H. Dreyling
Honoraria - Genentech
Research Funding - Genentech
Anton Hagenbeek
No relevant relationships to disclose
Pier Luigi Zinzani
Consultant or Advisory Role - Genentech
Bruce D. Cheson
Consultant or Advisory Role - Genentech
Research Funding - Genentech
Sreenivasu Yalamanchili
Employment or Leadership Position - Genentech
Stock Ownership - Genentech
Dan Lu
Employment or Leadership Position - Genentech
Stock Ownership - Genentech
Akiko Chai
Employment or Leadership Position - Genentech
Stock Ownership - Genentech
Yu-Waye Chu
Employment or Leadership Position - Genentech
Stock Ownership - Genentech
Jeff Porter Sharman
Research Funding - Genentech